[PDF][PDF] Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
M He, D Zhang, Y Cao, C Chi, Z Zeng, X Yang, G Yang… - Heliyon, 2023 - cell.com
Recent immunotherapy research has focused on chimeric antigen receptor-modified T cells
(CAR-Ts). CAR-T therapies have been clinically applied to manage hematologic …
(CAR-Ts). CAR-T therapies have been clinically applied to manage hematologic …
[HTML][HTML] Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
Z Cui, F Zou, R Wang, L Wang, F Cheng… - World Journal of …, 2023 - Springer
Background Although WD repeat and high-mobility group box DNA binding protein 1
(WDHD1) played an essential role in DNA replication, chromosome stability, and DNA …
(WDHD1) played an essential role in DNA replication, chromosome stability, and DNA …
[HTML][HTML] Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma
J Wang, C Liu, R Hu, L Wu, C Li - Frontiers in Pharmacology, 2024 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide and
accounts for more than 90% of primary liver cancer. The advent of immune checkpoint …
accounts for more than 90% of primary liver cancer. The advent of immune checkpoint …
[HTML][HTML] Liver Transplantation for Hepatocellular Carcinoma beyond the Milan Criteria: A Specific Role for Living Donor Liver Transplantation after Neoadjuvant …
O Rohland, L Freye, L Schwenk, A Ali-Deeb, M Ardelt… - Cancers, 2024 - mdpi.com
Simple Summary This research delves into better treatment options for patients with liver
cancer (HCC) who fall outside the eligibility criteria of traditional Milan guidelines for liver …
cancer (HCC) who fall outside the eligibility criteria of traditional Milan guidelines for liver …
Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE
L Diao, C Wang, R You, B Leng, Z Yu… - Journal of …, 2024 - Wiley Online Library
Abstract Background and Aim The study aims to investigate the efficacy and safety of hepatic
arterial infusion chemotherapy (HAIC) combined with lenvatinib and immune checkpoint …
arterial infusion chemotherapy (HAIC) combined with lenvatinib and immune checkpoint …
The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion
Studying lung adenocarcinoma (LUAD) early carcinogenesis is challenging, primarily due to
the lack of LUAD precursors specimens. We amassed multi-omics data from 213 LUAD and …
the lack of LUAD precursors specimens. We amassed multi-omics data from 213 LUAD and …
Association of HLA-G 3'UTR Polymorphisms with hepatitis B virus infection in Tunisian population
AB Laaribi, A Mehri, HB Yahia, H Chaouch, W Babay… - 2024 - researchsquare.com
Background Hepatitis B virus (HBV) infection is a major public health burden. The
mechanisms of immune evasion during chronic HBV (CHB) infection are poorly understood …
mechanisms of immune evasion during chronic HBV (CHB) infection are poorly understood …
Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria
O Rohland, L Freye, L Schwenk, A Ali-Deeb, M Ardelt… - 2024 - preprints.org
Purpose: This study aimed to elucidate the various new classifications and the use of LDLT
in this context for HCC beyond milan criteria. Methods: The clinical data of patients with HCC …
in this context for HCC beyond milan criteria. Methods: The clinical data of patients with HCC …